No results for ‘’
Lactose (India) Ltd
₹127.75
(5.19%)
Mon, 25 May 2026, 04:48 pm
Health Technology
Pharmaceuticals: Major
24.5KLactose (India) Return on Equity (ROE) History
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 3.35 | 7.60 | 65.14 | 13.85 | 8.50 | 6.41 | 10.82 | 302.33 | 42.92 | 22.42 | 36.49 | 0 | 47.94 | 237.62 | 0 | 28.57 | 45.81 | 25.87 | 21.83 |
| Price to book ratio | 0.04 | 0.05 | 0.31 | 0.68 | 0.55 | 0.34 | 0.79 | 0.51 | 1.43 | 3.32 | 3.91 | 3.29 | 1.02 | 0.50 | 0.87 | 1.92 | 1.37 | 3.73 | 1.90 |
| Price to sales ratio | 0.01 | 0.02 | 0.14 | 0.30 | 0.24 | 0.13 | 0.23 | 0.32 | 0.93 | 1.82 | 2.85 | 3.17 | 0.85 | 0.43 | 0.79 | 1.52 | 0.84 | 1.54 | 0.97 |
| Price to cash flow ratio | 0.19 | 0.12 | 1.54 | 2.81 | 18.57 | 0 | 0.74 | 1.07 | 2.08 | 0 | 29.04 | 0 | 0 | 8.45 | 0 | 20.03 | 28.27 | 48.17 | 0 |
| Enterprise value | 61.25M | 90.71M | 99.76M | 130.58M | 128.03M | 93.5M | 171.69M | 290.67M | 592.09M | 973.22M | 1.36B | 1.34B | 696.26M | 546.78M | 710.19M | 1.09B | 929.18M | 2.13B | 1.65B |
| Enterprise value to EBITDA ratio | 4.65 | 7.93 | 3.96 | 5.81 | 5.32 | 0 | 5.96 | 39.48 | 13.24 | 9.30 | 11.88 | 23.44 | 7.28 | 5.92 | 10.59 | 8.81 | 8.17 | 11.20 | 9.65 |
| Debt to equity ratio | 0.74 | 1.06 | 0.78 | 0.63 | 0.58 | 0.41 | 0.57 | 1.60 | 2.52 | 1.77 | 1.32 | 1.21 | 1.05 | 1.15 | 1.32 | 1.05 | 0.95 | 0.83 | 0.97 |
| Return on equity % | 0 | 0.68 | 0.50 | 4.92 | 6.85 | 5.64 | 7.26 | 0.19 | 3.40 | 16.10 | 12.19 | -4.82 | 2.21 | 0.21 | -7.14 | 6.59 | 3.03 | 15.49 | 9.76 |
Lactose (India) Ltd Return on Equity
The Lactose (India) Ltd Return on Equity is a key financial metric used by investors to evaluate Lactose (India) Ltd's valuation, profitability, and overall financial performance. Tracking the Lactose (India) Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Lactose (India) Ltd (NSE: , BSE: 524202) is currently trading at ₹127.75, with a market capitalization of ₹1.52B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Lactose (India) Ltd Return on Equity is essential for fundamental analysis.
Lactose (India) Ltd Return on Equity Current Value
The current Lactose (India) Ltd Return on Equity stands at 9.76.
The Lactose (India) Ltd Return on Equity has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Lactose (India) Ltd Return on Equity Historical Trend
The Lactose (India) Ltd Return on Equity has shown the following historical trend:
- 2024: 9.76
- 2023: 15.49
- 2022: 3.03
- 2021: 6.59
- 2020: -7.14
The decline in Lactose (India) Ltd Return on Equity indicates improving financial efficiency or better earnings growth.
What Lactose (India) Ltd Return on Equity Indicates for Investors
The Lactose (India) Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.
ROE indicates how efficiently the company generates returns for shareholders.
Lactose (India) Ltd Return on Equity Analysis Summary
The Lactose (India) Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Lactose (India) Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Lactose (India) Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.